Alan P Timmins - Net Worth and Insider Trading

Alan P Timmins Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alan P Timmins owns 3 companies in total, including CytoDyn Inc (CYDY) , US Stem Cell Inc (USRM) , and Sarepta Therapeutics Inc (SRPT) .

Click here to see the complete history of Alan P Timmins’s form 4 insider trades.

Insider Ownership Summary of Alan P Timmins

Ticker	Comapny	Transaction Date	Type of Owner
CYDY	CytoDyn Inc	2021-10-18	director
USRM	US Stem Cell Inc	2008-10-22	director
SRPT	Sarepta Therapeutics Inc	2005-02-22	director & President & COO

Alan P Timmins Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alan P Timmins Ownership Network

Ownership Network List of Alan P Timmins

No Data

Ownership Network Relation of Alan P Timmins

Alan P Timmins Owned Company Details

What does CytoDyn Inc do?

Who are the key executives at CytoDyn Inc?

Alan P Timmins is the director of CytoDyn Inc. Other key executives at CytoDyn Inc include EVP of Legal Affairs Tyler Blok , President Arvin Cyrus Arman , and Chief Financial Officer Antonio Migliarese .

CytoDyn Inc (CYDY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CytoDyn Inc (CYDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CytoDyn Inc (CYDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CytoDyn Inc (CYDY)'s detailed insider trading history can be found in Insider Trading Tracker table.

CytoDyn Inc Insider Transactions

No Available Data

What does US Stem Cell Inc do?

Who are the key executives at US Stem Cell Inc?

Alan P Timmins is the director of US Stem Cell Inc. Other key executives at US Stem Cell Inc include Chief Science Officer Kristin C Comella , Vice President,Sales&Marketing Matthew J Fendrich , and VP of Financial Operations Nicholas M Burke .

US Stem Cell Inc (USRM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of US Stem Cell Inc (USRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of US Stem Cell Inc (USRM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

US Stem Cell Inc (USRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

US Stem Cell Inc Insider Transactions

No Available Data

What does Sarepta Therapeutics Inc do?

Who are the key executives at Sarepta Therapeutics Inc?

Alan P Timmins is the director & President & COO of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Tech Ops Officer Bilal Arif , Chief Financial Officer Ian Michael Estepan , and SVP & General Counsel Ryan Edward Brown .

Sarepta Therapeutics Inc (SRPT) Insider Trades Summary

Over the past 18 months, Alan P Timmins made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 68,532 shares made by Michael Andrew Chambers , a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf , and a net purchase of 50,000 shares made by Richard Barry .

In summary, during the past 3 months, insiders sold 19,396 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 19,396 shares. During the past 18 months, 42,731 shares of Sarepta Therapeutics Inc (SRPT) were sold and 143,757 shares were bought by its insiders, resulting in a net purchase of 101,026 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sarepta Therapeutics Inc Insider Transactions

No Available Data

Alan P Timmins Mailing Address

Above is the net worth, insider trading, and ownership report for Alan P Timmins. You might contact Alan P Timmins via mailing address: 1111 Main Street, Suite 600, Vancouver Wa 98660.

Discussions on Alan P Timmins

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.